
Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
Author(s) -
Chebib Nader,
Cottin Vincent,
TaharoAgRalissoum Martine,
Chuzeville Michel,
Mornex JeanFrançois
Publication year - 2018
Publication title -
pulmonary circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.791
H-Index - 40
ISSN - 2045-8940
DOI - 10.1177/2045893217753352
Subject(s) - medicine , treprostinil , sildenafil , ambrisentan , bosentan , iloprost , pulmonary hypertension , tadalafil , right ventricular hypertrophy , vascular resistance , intensive care medicine , prostacyclin , cardiology , hemodynamics , endothelin receptor , receptor
Nader Chebib, Vincent Cottin, Martine Taharo-Ag-Ralissoum, Michel Chuzeville and Jean-François Mornex Hospices Civils de Lyon, National Reference Center for Rare Pulmonary Diseases, Competence Center for Pulmonary Hypertension, Lyon, France; Claude Bernard Lyon 1 University, University of Lyon, Lyon, France; Hospices Civils de Lyon, Hôpital Edouard Herriot, Cardiogeriatrics Department, Lyon, France